Connect with us

Hi, what are you looking for?

Economy

Millions spent by Biden on COVID ‘vaccine hesitancy’ campaign slashed by Trump NIH: report

The National Institutes of Health (NIH) is reportedly gearing up to cancel dozens of research grants about vaccine hesitancy by the end of the month, just four years after the Biden administration poured millions of dollars into combating COVID-19 vaccine skepticism.

According to an internal email obtained by The Washington Post this week with the subject line ‘required terminations — 3/10/25,’ the agency had ‘received a new list… of awards that need to be terminated, today. It has been determined they do not align with NIH funding priorities related to vaccine hesitancy and/or uptake.’

More than 40 grants are on the chopping block, according to the Post’s report, and when notifying researchers of the NIH’s termination, they should be told ‘not to prioritize research activities that focuses gaining scientific knowledge on why individuals are hesitant to be vaccinated and/or explore ways to improve vaccine interest and commitment.’

Fox News Digital has reached out to NIH and the Department of Health and Human Services (HHS) for comment.

The report comes four years after the previous Biden administration spent millions to combat ‘misinformation,’ particularly related to the COVID-19 vaccine, in 2021. A November report by Open the Books, a government watchdog group, found that at least $267 million was spent on research grants and contracts related to ‘misinformation’ or ‘disinformation.’ 

The Centers for Disease Control and Prevention (CDC) allocated more than $17 million over three weeks in February 2021, CBS News reported at the time, to 15 organizations advocating for Black, Hispanic, Asian and Native American populations. Progressive groups UnidosUS and National Urban League were granted $3.2 million and $2 million, respectively.

In a now-archived CDC page titled ‘Risk for COVID-19 Infection, Hospitalization, and Death By Race/Ethnicity’ in December 2022, the department reported that Black people are more likely to contract COVID-19 than White people.

‘Sure enough, the feds have spent at least $127 million in grants specifically targeted to study the spread of ‘misinformation’ — or to help people ‘overcome’ it, so to speak — by persuading them to go along with COVID-related public health recommendations and mandates,’ the Open the Books report said.

It’s unclear if the cancelation of grants came from Health and Human Services Secretary Robert F. Kennedy, Jr., but the Trump administration has been highly critical of the previous administration’s spending. Tech billionaire Elon Musk, head of the Department of Government Efficiency (DOGE), has also been taking a scalpel to DEI-related funding amid President Donald Trump’s effort to downsize the government workforce. 

Kennedy has been focusing on reforming food policies, expanding healthcare coverage and holding big pharmaceutical companies accountable since his controversial Senate confirmation last month.

This post appeared first on FOX NEWS






    You May Also Like

    Investing

    Overview The world of business technology has evolved. Driven by the shift towards distributed work and cloud application delivery, enterprise infrastructure is undergoing a...

    Investing

    Overview Hempalta Corp. (TSXV:HEMP) is engaged in processing industrial hemp at scale to produce a range of consumer and commercial products. Its proprietary processing...

    Investing

    Overview ALX Resources (TSXV:AL,FWB:6LLN,OTC:ALXEF) is dedicated to providing shareholders with multiple opportunities for discovery by exploring a portfolio of prospective mineral properties, which include...

    Investing

    Overview Flynn Gold Limited (ASX: FG1) is an Australian mineral exploration company with a portfolio of projects in Tasmania and Western Australia. Tasmania is...

    Disclaimer: gorgeousincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 gorgeousincome.com